Sale!

BCR-ABL1 Quantitative Test for Leukaemia Monitoring

Original price was: R4,000.Current price is: R3,000.

-25%

The BCR-ABL1 Quantitative test is your essential partner in monitoring chronic myeloid leukaemia (CML) and acute lymphoblastic leukaemia (ALL) treatment response. For just ZAR 3,000 (regularly ZAR 4,000), this precise molecular test provides crucial insights into your treatment effectiveness, helping your healthcare team make informed decisions about your care. Using advanced Real Time PCR technology, we deliver highly accurate results within 3-4 days, giving you the clarity and confidence you need during your cancer journey. Whether you’re in Johannesburg, Cape Town, Durban or Pretoria, our nationwide network ensures accessible, reliable testing with the professional expertise you deserve. Early detection and regular monitoring can significantly improve treatment outcomes and quality of life.

📞 24/7 South African Support Team Call : +27 6412 56421

  • ✓ ISO Accredited Lab Reports
  • ✓ Free Genetic Counseling Included
  • 🔒 100% Confidential & Secure Testing
Guaranteed Safe Checkout

BCR-ABL1 Quantitative Test ZAR 3
BCR-ABL1 Quantitative Test for Leukaemia Monitoring
R4,000 Original price was: R4,000.R3,000Current price is: R3,000.

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Take Control of Your Leukaemia Journey with Precise BCR-ABL1 Monitoring

Living with chronic myeloid leukaemia or acute lymphoblastic leukaemia can feel overwhelming, but having clear, accurate information about your treatment response brings peace of mind and empowers your healthcare decisions. Our BCR-ABL1 Quantitative test provides the precise monitoring you need to stay ahead of your condition.

Understanding Your BCR-ABL1 Quantitative Test

The BCR-ABL1 Quantitative test is a sophisticated molecular diagnostic tool that measures the amount of BCR-ABL1 fusion genes in your blood or bone marrow. This genetic abnormality is the hallmark of chronic myeloid leukaemia (CML) and some cases of acute lymphoblastic leukaemia (ALL). By quantifying these genes, we can precisely track how well your treatment is working and detect any changes early.

Using cutting-edge Real Time PCR technology, we provide highly sensitive and specific results that guide your oncologist in making the best treatment decisions for your unique situation.

Who Should Consider This Essential Test?

This test is crucial for:

  • Patients diagnosed with CML – for ongoing treatment monitoring and response assessment
  • Individuals with ALL – when BCR-ABL1 positivity is suspected or confirmed
  • Those experiencing treatment changes – to evaluate new medication effectiveness
  • Patients concerned about disease progression – for early detection of molecular relapse
  • Individuals preparing for treatment adjustments – providing data-driven insights for your care team

If you’re currently undergoing leukaemia treatment or your doctor has recommended monitoring, this test provides the critical information needed to optimise your care.

Why Regular BCR-ABL1 Monitoring Matters for Your Health

Regular monitoring with the BCR-ABL1 Quantitative test offers life-changing benefits:

  • Early Detection of Treatment Resistance – Identify potential issues before they become serious problems
  • Personalised Treatment Adjustments – Ensure your medication dosage is optimised for your specific response
  • Peace of Mind – Receive objective data about your treatment effectiveness
  • Improved Quality of Life – Better disease control means fewer symptoms and complications
  • Long-term Health Planning – Make informed decisions about your future care with confidence

Understanding Your Test Results with Confidence

We understand that waiting for test results can be anxiety-provoking. Our team provides clear, comprehensive reports that your oncologist will discuss with you in detail. Your results will show:

  • BCR-ABL1 Transcript Levels – The precise measurement of fusion genes
  • Treatment Response Classification – How your current treatment is performing
  • Trend Analysis – Comparison with previous results to track progress
  • Clinical Recommendations – Clear guidance for next steps in your care

Remember, your results are just one piece of your overall health picture, and your healthcare team will interpret them in the context of your complete medical situation.

Affordable, Life-Saving Monitoring Within Reach

Test Option Regular Price Special Price Savings
BCR-ABL1 Quantitative Test ZAR 4,000 ZAR 3,000 ZAR 1,000

Turnaround Time: 3-4 days
Sample Type: Bone marrow / Peripheral blood (Transport immediately)
Components: EDTA Vacutainer (4ml)

Consider this investment in your health: regular monitoring can prevent costly hospitalisations and complications down the line.

Why Thousands of South Africans Trust Oracle Genomics

We’ve built our reputation on accuracy, reliability, and patient care:

  • Nationwide Coverage – Accessible testing centres in Johannesburg, Cape Town, Durban, Pretoria and across South Africa
  • Medical Expertise – Our tests are conducted by qualified professionals using state-of-the-art technology
  • Rapid Results – Get your crucial results within 3-4 days to inform timely treatment decisions
  • Patient-Focused Approach – We understand the emotional journey of cancer treatment and provide compassionate support
  • Quality Assurance – Every test undergoes rigorous quality control to ensure accuracy you can depend on

Take the Next Step in Your Health Journey Today

Don’t wait to get the clarity you need about your treatment response. Early and regular monitoring can make a significant difference in your leukaemia management and overall quality of life.

Important Note: This test requires a doctor’s prescription (not applicable for surgery, pregnancy cases, or travel abroad purposes).



Limited time special pricing available. Take action today for peace of mind tomorrow.